Cyclobenzaprine Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Cyclobenzaprine Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

CYCLOBENZAPRINE HYDROCHLORIDE DESCRIPTION


Cyclobenzaprine Hydrochloride




CLINICAL PHARMACOLOGY







PRECAUTIONS, Use in the ElderlyPRECAUTIONS, Impaired Hepatic Function














ADVERSE REACTIONS

INDICATIONS & USAGE






CYCLOBENZAPRINE HYDROCHLORIDE CONTRAINDICATIONS






WARNINGS

ADVERSE REACTIONS


PRECAUTIONS




CLINICAL PHARMACOLOGY, Pharmacokinetics, Hepatic Impairment



CONTRAINDICATIONS
















CLINICAL PHARMACOLOGY, Pharmacokinetics, Elderly

CYCLOBENZAPRINE HYDROCHLORIDE ADVERSE REACTIONS

































DRUG ABUSE AND DEPENDENCE



OVERDOSAGE


As management of overdose is complex and changing, it is recommended that the physician contact a poison control center for current information on treatment.






As management of overdose is complex and changing, it is recommended that the physician contact a poison control center for current information on treatment.












DOSAGE & ADMINISTRATION

INDICATIONS AND USAGE
PRECAUTIONS, Impaired Hepatic FunctionUse in the Elderly

HOW SUPPLIED







STORAGE AND HANDLING




PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Cyclobenzaprine Hydrochloride

Cyclobenzaprine Hydrochloride

Cyclobenzaprine Hydrochloride TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-891(NDC:65162-541)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
CYCLOBENZAPRINE HYDROCHLORIDE CYCLOBENZAPRINE 10 mg

Inactive Ingredients

Ingredient Name Strength
CROSCARMELLOSE SODIUM
D&C YELLOW NO. 10
FD&C BLUE NO. 2
FD&C YELLOW NO. 6
lactose monohydrate
MAGNESIUM STEARATE
cellulose, microcrystalline
polyethylene glycol
POLYVINYL ALCOHOL
SILICON DIOXIDE
talc
titanium dioxide

Product Characteristics

Color Size Imprint Code Shape
yellow 8 mm AN41 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-891-16 50 in 1 VIAL

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078218 2012-03-05


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.